Smoking and Bladder Cancer Risk in Egypt
Author Information
Author(s): A Lafuentel, MM Zakahary, MAA El-Aziz, C Ascaso, MJ Lafuente, M Trias, P Carretero
Primary Institution: Institut de Salut Pública, University of Barcelona
Hypothesis
Does GSTM1 deficiency increase the risk of squamous cell carcinoma of the bladder in schistosomiasis patients who smoke?
Conclusion
The study found that male smokers with GSTM1 deficiency have a significantly higher risk of developing squamous cell carcinoma of the bladder.
Supporting Evidence
- 60% of smokers in the SCC group were heavy smokers.
- 69% of SCC male smokers had a negative GSTM1 phenotype.
- The study suggests a synergistic effect of smoking and GSTM1 deficiency on bladder cancer risk.
Takeaway
If you smoke and lack a certain enzyme called GSTM1, you might be more likely to get a type of bladder cancer.
Methodology
The study recruited 80 bladder SCC patients and 70 control individuals, measuring GSTM1 levels in blood samples and assessing smoking history.
Potential Biases
Potential bias due to the recruitment of patients from a single institution and the focus on male participants.
Limitations
The study primarily focused on male patients, and the results for female patients were only included for descriptive purposes.
Participant Demographics
66 male and 14 female bladder SCC patients, with a mean age of 45.2 years for men and 41.0 years for women.
Statistical Information
P-Value
0.007
Confidence Interval
1.06-21.77
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website